Home

Schizophrenia

Depression, Schizophrenia

Read time: 3 min

ICD-11: new and fit for clinical utility and consistency

The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to...

Bipolar, Schizophrenia

Read time: 3 min

Could therapeutic manipulation of critical periods of brain development benefit mental health?

Many critical periods of brain development occur during infancy and childhood. When these periods...

Read time: 4 min

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Bipolar, Schizophrenia

Read time: 3 min

Brain connectivity in early psychosis and during effective antipsychotic therapy

Resting state functional MRI of the brain is providing fascinating insights into the connectivity...

Read time: 3 min

Schizophrenia and identifying those at high risk – the LJ Seidman memorial lecture

Tribute was paid to the late Larry Seidman during a memorial lecture highlighting his and ongoing...

Bipolar, Schizophrenia

Read time: 2 min

The OPUS Panel — Sharing lived experiences of mental illness

A group of young people and their relatives (the OPUS Panel) aims to reduce societal prejudices and...

Read time: 4 min

Improving long-term outcomes in schizophrenia — translating evidence into practice

The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse...

Depression, Schizophrenia

Read time: 3 min

Making primary care count in mental health provision

In countries with few resources, some recovering from conflict, mental healthcare does not...

Depression, Schizophrenia

Read time: 3 min

Inspiring efforts to improve mental health across countries and ages

Mental ill-health in megacities was the theme for a presidential plenary session at 18th World...

Read time: 3 min

Congress highlights

Transforming healthcare — the changing landscape of patient engagement

Patient engagement is the facilitation and strengthening of the role of patients as co-producers of...

Read time: 3 min

Congress highlights

Early dialogues with patients are informing medicines development

A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...

Read time: 3 min

Future of schizophrenia treatment: Where do we go now?

Over the next decade, the outcomes for patients with schizophrenia should improve considerably,...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country